P
eriprosthetic joint infection is a devastating complication after total knee arthroplasty (TKA). Between 2005 and 2006, 25% of revisions were to manage infection. 1 Demand for primary TKA in the United States is projected to grow by 673% to 3.48 million procedures by 2030. 2 This would translate into a huge number of patients experiencing periprosthetic joint infections, with the care of these patients representing a substantial financial burden to society. The surgical options for treatment of periprosthetic infection include irrigation and débride-ment with polyethylene exchange (IDPE), single-stage revision, or 2-stage revision (2SR).
Irrigation and débridement with polyethylene exchange is an attractive alternative for both patient and surgeon. Compared with a 2SR, benefits of an IDPE include retention of implants, preservation of bone stock, shorter procedure duration, less chance of intraoperative fracture from removal of components and implantation of cement spacers, and faster postoperative rehabilitation. [3] [4] [5] However, the reported success rate of IDPE is variable, with reports ranging from 29% to 83%. [6] [7] [8] [9] [10] By comparison, 2SR is considered the gold standard, with success rates reported in the range of 75%-100%. [11] [12] [13] [14] [15] [16] [17] In addition, it has been reported that failure rates of 2SR for TKA infections are higher in patients treated with previous IDPE than in patients who did not receive IDPE. 18 Therefore, surgeons considering IDPE need to balance potential benefits of the procedure with the lower eradication rate and potentially decreased chance of eradication should the patient ultimately receive 2SR.
There may be a role for IDPE in certain situations, such as the treatment of acute postoperative and acute hematogenous infections. 19 An acute postoperative infection has been defined as one that occurs within the first 4 weeks after index TKA. 20 Other studies are more reserved in their recommendations and state that IDPE should be consider ed only in immunologically optimized patients with acute nonStaphylococcal infections. 21 Although there is an abundance of literature studying the successful eradication rates with IDPE and 2SR, there is a paucity of data reporting on the patient experience or patient satisfaction associated with these revision procedures. Understanding patient-reported satisfaction is important to the treatment decision process. Therefore, the purpose of this study was to examine patientreported outcomes in patients with infected TKAs based on whether the patients were treated with initial 2SR, successful IDPE, or failed IDPE with subsequent 2SR; to compare each of the above cohorts to a matched control group of patients with noninfected TKAs; and to determine the success rates of 2SR and IDPE in our study population.
Methods
After obtaining institutional review board approval, we performed a database query to identify patients whose index TKAs, performed between May 1991 and November 2011, were acutely infected. Inclusion criteria for our retrospective review were a minimum 1-year follow-up after surgical treatment of infection.
All procedures were performed by 1 of 7 surgeons at our institution. All 7 are high-volume, arthroplasty fellowship-trained surgeons. Implant type for the index procedures included varying levels of constraint, including posterior stabilized, varus-valgus constrained nonhinged, and hinged knees.
In 2011, The Musculoskeletal Infection Society created guidelines for the diagnosis of periprosthetic joint infection (PJI). A definite diagnosis of PJI can be made when the following conditions are met. 22 • Sinus tract communicating with the prosthesis.
• Pathogen isolated by culture from 2 separate tissue or fluid samples obtained from the affected prosthetic joint.
• Presence of at least 4 of the following: elevated serum erythrocyte sedimentation rate (ESR) or serum C-reactive protein (CRP) concentration, elevated synovial white blood cell count, elevated synovial neutrophil percentage, presence of purulence in the affected joint, isolation of a microorganism in 1 culture of periprosthetic tissue or fluid, and more than 5 neutrophils per highpower field in 5 high-power fields observed from histologic analysis of periprosthetic tissue at ×400 magnification. At our institution, diagnosis of infection follows these criteria, with the whole clinical picture used to guide treatment. Threshold values for ESR and CRP in the present study were are 30 mm/hr and 10 mg/L, respectively. We excluded patients with less than 1 year of complete follow-up.
Identified patients were matched to a control cohort of patients with noninfected primary TKAs based on age and the age-adjusted Charlson Comorbidity Index (CCI) score. The CCI score is a validated method of estimating risk of death from comorbid disease and has also been found to correlate well with major complications in revision surgery. 23, 24 Patients with a surgically managed infected TKA were then divided into either the 2SR or IDPE group based on intention to treat. The type of treatment performed was at the discretion of the treating surgeon. The IDPE group was then further subdivided based on whether the IDPE was successful or unsuccessful at eradicating infection; patients in whom IDPE was not successful required subsequent 2SR. Both acute hematogenous and acute postoperative infections were defined as those presenting within 4 weeks of onset of symptoms. We considered the infection to be eradicated when the inflammatory markers had normalized, the clinical symptoms had improved and the surgical wound had healed.
Functional outcomes and reoperations associated with unsuccessful eradication of infection were reviewed. We used the most recent patient-reported scores and range of motion (ROM) for analysis. For patients who had unsuccessful IDPE and required subsequent 2SR, clinical outcomes were measured at their most recent follow-up (i.e., after their 2SR). We calculated CCI scores based on a review of patient charts. At each clinic visit, ROM was recorded using a goniometer; ROM at the initial visit and at latest review was used in this study. Western Ontario and McMaster Universities Arthritis Index (WOMAC), Knee Society Clinical Rating System (KSS) and the 12-item Short-Form Health Survey (SF12) scores were recorded from standardized forms that are routinely used for all arthroplasty patients at our institution. All 3 scores have been validated for use in quantifying knee pain and function. [25] [26] [27] 
Statistical analysis
We used the Statistical Package for the Social Sciences (SPSS Inc.) for the statistical analysis. We used the Student t test for parametric comparisons and the MannWhitney U test for nonparametric comparisons between the groups. The Mann-Whitney U test was used when data for a particular variable did not meet the distribution assumptions required by their parametric counterpart.
Results
During our study period, 1857 knee revisions were performed at our institution. Review of our database identified 145 infected TKAs in 145 patients. Of the 145 patients with infected TKAs, 91 were treated initially with 2SR and 54 were treated with IDPE. Of the 91 patients treated with 2SR, 79 had successful eradication of infection and 12 had reoperations for infection. Of the 54 patients treated with IDPE, 21 had successful infection eradication and 33 had a persistent infection and required 2SR (Fig. 1) . All of the patients in our cohort in whom IDPE failed received a subsequent 2SR. Of the 21 patients in whom IDPE was successful, 9 had their infections diagnosed during the acute postoperative period and 12 had diagnoses of acute hematogenous infection. Of the 33 patients in whom IDPE was unsuccessful, 4 had their infections diagnosed during the acute postoperative period and 29 patients had diagnoses of acute hematogenous infection (Fig. 1) . In other words, acute postoperative infection in our patient cohort represented 43% of successful IDPE and 12% of failed IDPE.
There was no difference in age, CCI scores or body mass index between controls and patients with infected TKAs (Table 1) . Mean clinical follow-up for patients with infected TKAs was 64.2 (range 12-237) months compared with 35.4 (range 24-120) months in the control group (p < 0.001; Table 1 ).
For the successful IDPE cohort, 6.7% of patients had a hinged prosthesis and 93.3% had posterior stabilized prostheses. All patients in the failed IDPE group had posterior stabilized prostheses. In the 2SR group, 6.1% had a hinged prosthesis, 57.3% had varus-valgus constrained prostheses, and 36.6% had posterior stabilized prostheses. The mean duration from initial arthroplasty surgery to the 2SR was 31.7 (range 2-180) months. The mean duration from initial (Table 2) . When the 2SR group was divided into successful and failed 2SR, the control group performed better than both on all measured outcomes (all p < 0.05). Similarly, the control group performed better on all measures than the failed IDPE group (all p < 0.05; Table 3 ). Comparing the failed IDPE group with the 2SR group revealed no difference in any outcome (all p > 0.05; Table 4 ). Comparing the control group with the successful IDPE group demonstrated no difference in any measured outcome (all p > 0.05; Table 5 ). The success rate with IDPE was 39% and the success rate with 2SR was 87% in our cohorts.
Discussion
Periprosthetic joint infection continues to be a challenge in TKA for both patients and surgeons. Twenty-fice percent of revisions are done as a result of infection, 1 with an incidence rate of 1% for TKA. 28 The optimal treatment for patients with infected TKAs is controversial. While 2SR remains the gold standard in treatment with an eradication rate ranging from 75% to 100%, [11] [12] [13] [14] [15] [16] [17] there is no clear consensus on the role of IDPE in the treatment of periprosthetic infection. Compared with 2SR, the benefits of IDPE include retention of implants with preservation of bone stock, shorter procedure durations, decreased chance of intraoperative fracture from removal of components with implantation of cement spacers, and faster postoperative rehabilitation. [3] [4] [5] The main arguments against the use of IDPE as a treatment option have centered on its low success rate at eradicating infection and on the possibility that IDPE may reduce the success rate of a subsequent 2SR. 18 There is an abundance of literature on the treatment of an infected TKA with success rates of IDPE reported to range from 29% to 83%.
6-10 Therefore, we elected not to focus on success or failure rates of eradication. Instead, the aim of the present study was to add to the body of literature by being, to our knowledge, the first study to focus on patient-reported outcomes based on treatment provided.
Our results demonstrate that there is no difference in patient-reported clinical outcomes when comparing unsuccessful IDPE and 2SR. Most interestingly, we found no difference in any outcome when comparing the control group with the successful IDPE group. These findings are important when counselling a patient on the treatment options available for an infected TKA. The improved satis faction of a successful IDPE must be weighed against the lower rates of successful eradication, and these issues need to be discussed with the patient. In our cohort, IDPE resulted in an eradication rate of 39%, which is consistent with rates reported in the litera ture. [6] [7] [8] [9] [10] Similarly, the eradication rate after 2SR in our cohort was 87%, which is also consistent with published rates. [11] [12] [13] [14] [15] [16] [17] Treatment with IDPE is more likely to be suc cessful in cases of acute postoperative and acute hemato genous infections. 19 The failed IDPE group in our study had a greater proportion of acute hematogenous infection than the successful IDPE group. It is possibile that some of our patients in whom IPDE failed actually had misdiag nosed chronic infections. However, the 39% eradication rate in our study is consistent with that reported in previ ous studies evaluating IDPE for infected TKAs. [6] [7] [8] [9] [10] Fur thermore, the main purpose of the present study was to report on outcomes based on the treatment patients received rather than the success or failure of eradication.
Limitations
The study limitations were as follows. First, this study involved a retrospective review and was therefore subject to all the biases associated with this type of study design. Second, some patients in whom IDPE failed had been referred from other hospitals. As the referring surgeons followed IDPE treatment protocols similar to those at our tertiary care centre, these patients were included in the current study to maximize cohort size. Third, it should be noted that there is a difference between the infected and control cohorts with regards to mean duration of follow up (64.2 mo in the infected cohorts v. 35.4 mo in the con trol cohort). The control cohort was selected by matching patients with noninfected primary TKAs with patients in the infected cohort based on age and ageadjusted CCI scores. This process resulted in a comparable control cohort in terms of patient number, age, ageadjusted CCI and body mass index. As a result of the matching process, there was a difference in mean duration of followup between the cohorts. However, since previous literature has demonstrated that clinical outcome scores do not change significantly beyond 18 months after surgery, 29, 30 the comparison of clinical outcomes in the cohorts is still relevant despite the differential followup. Finally, the data included in the current study depend on the quality of the data recorded in the medical records and are there fore subject to the limitations faced by many retrospective cohort designs. In some cases the onset of symptoms were not well recorded in terms of hours and/or days. There fore, although we could definitively identify that patients fit our definition of acute symptoms (< 4 wk), in some cases we were unable to reliably calculate an hour or day value for onset of symptoms. As a result we have not pre sented these data in our study.
The main strength of this study is that it offers a unique look at a large patient cohort experiencing a difficult compli cation after TKA. It also examines how different treatment algorithms affect patientreported outcomes and ROM after treatment of infection. To our knowledge, patientreported outcomes have previously not been published in the litera ture or been considered as part of the controversy regarding the appropriate management of the infected TKA.
ConClusion
There may be a role for IDPE in the treatment of peripros thetic infections owing to the potential for greater patient satisfaction with IDPE than with 2SR. The improved satis faction associated with a successful IDPE must be weighed against its lower rate of successful eradication of infection. By attempting to identify the patients in whom IDPE is most likely to succeed, a surgeon can maximize patient out comes when dealing with periprosthetic infection.
